Cullinan Therapeutics Income Statement (2020-2023) | CGEM

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Revenue & cost
Revenue 18.94M
Operating items
Research & Development 12.41M11.78M12.68M20.88M24.54M26.41M19.68M21.32M52.10M27.39M33.82M34.85M
Selling, General & Administrative 5.16M4.83M5.70M13.47M8.12M10.70M10.09M11.29M10.66M10.21M10.98M10.64M
Operating Expenses 17.57M16.60M18.38M34.35M32.66M37.11M29.77M32.61M62.76M37.60M44.80M45.48M
Operating Income 1.37M-16.60M-18.38M-34.35M-32.66M239.68M-29.77M-32.61M-62.76M-37.60M-45.24M-45.48M
EBIT 1.37M-16.60M-18.38M-34.35M-32.66M239.68M-29.77M-32.61M-62.76M-37.60M-45.24M-45.48M
Non-operating items
Interest & Investment Income 0.05M0.17M0.12M0.14M0.20M0.70M2.35M3.36M4.51M5.32M5.88M5.92M
Other Non Operating Income -0.00M-0.01M-0.00M0.00M-0.24M0.30M0.11M0.07M0.18M-0.12M
Non Operating Income -0.00M-0.01M-0.00M0.00M-0.24M0.30M0.11M0.07M0.18M-0.12M
Net income details
EBT 1.42M-16.44M-18.26M-34.21M-32.46M240.13M-27.41M-28.95M-58.14M-32.21M-39.18M-39.69M
Tax Provisions -19.60M66.07M-2.52M-1.88M-14.12M
Profit After Tax 1.42M-16.44M-18.26M-34.21M-12.89M174.90M-24.89M-26.78M-58.14M-32.21M-39.18M-25.56M
Income from Non-Controlling Interests 1.50M-0.80M-0.91M-1.69M-0.79M-0.83M-0.09M-0.31M-0.18M-1.76M
Income from Continuing Operations 1.42M-16.44M-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M
Consolidated Net Income 1.42M-16.44M-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M
Income towards Parent Company 1.42M-16.44M-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M
Net Income towards Common Stockholders 1.42M-16.44M-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M
Additional items
EPS (Basic) 0.03-0.36-0.40-0.76-0.273.90-0.54-0.61-1.42-0.82-0.91-28.97
EPS (Weighted Average and Diluted) -0.01-0.40-0.76-0.273.77-0.54-0.58-1.42-0.82-0.91-28.97
Shares Outstanding (Weighted Average) 37.83M43.52M43.52M43.54M43.68M44.61M44.78M45.61M45.77M39.33M39.36M42.73M42.78M
Shares Outstanding (Diluted Average) 43.30M43.44M43.08M44.43M46.39M46.58M46.64M40.68M40.31M42.73M
EBITDA 1.36M-16.49M-18.20M-34.99M-32.66M239.68M-29.77M-32.61M-62.76M-37.60M-45.24M-45.48M
Shares Outstanding 20.04M20.04M20.04M29.83M43.52M43.53M43.66M44.29M44.66M45.40M45.74M45.80M39.34M42.74M42.76M
Tax Rate 60.3827.519.206.4935.59